Coramaze Technologies

Coramaze Technologies is a health care startup based in Germany and was founded in 2018. The company's slogan, "Filling the Cardiac Gap," resonates with its mission of saving lives by providing an innovative solution for tricuspid regurgitation. Coramaze's flagship product, the TriPair system, is designed to empower physicians with an easy, fast, and effective repair option, particularly for patients without access to alternative therapies. Notably, this device is anchored atraumatically in the right atrium, allowing for full retrievability and intra-procedural efficacy evaluation. The company, established in 2013, operates in both Germany and Israel, reflecting its commitment to advancing medical technology on a global scale. The latest notable investment in the company came in the form of a €4.50M Series A investment on 01 September 2015, which was provided by Elron Ventures. This fund injection underpins the confidence that esteemed investors have in Coramaze's potential to revolutionize cardiac care and improve patient outcomes. With such a pioneering approach and substantial backing, Coramaze Technologies is poised to make a meaningful impact in the medical device landscape, presenting an enticing opportunity for potential venture capital investment.